The Saudi Food and Drug Authority (SFDA) has approved Casgevy, the first gene therapy for sickle cell anemia and thalassemia diseases in patients 12 years of age and older.
The Saudi Food and Drug Authority (SFDA) has referred an establishment in Dammam to the Public Prosecution for tampering with dates of cosmetic products.
The International Committee for Medical Device Quality Standards in the International Organization for Standardization (ISO/TC 210) approved the proposal of Saudi Arabia to translate the international standards for managing the quality system of medical devices (ISO 13485:2016) and the management of the risks of medical devices (ISO 14791:2019) into the Arabic language.